The detection of anti-β2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 133, Issue 2, 2007, Pages 164-168

  Mezzesimi, A ^a   Florio, P ^a   Reis, F M ^b   D'Aniello, G ^a   Sabatini, L ^c   Razzi, S ^a   Fineschi, D ^c   Petraglia, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Anti 2 glycoprotein I; Anticardiolipin antibodies; Antinuclear antibodies; Lupus anticoagulants; Threatened abortion

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; IMMINENT ABORTION; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; BLOOD; COHORT ANALYSIS; IMMUNOLOGY; PREGNANCY; PROGNOSIS; RISK; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ABORTION, THREATENED; ADULT; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; COHORT STUDIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROGNOSIS; RISK;

EID: 34447579279     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.08.018     Document Type: Article

References (28)

1. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
2. Reznikoff-Etievant M.F., Cayol V., Zou G.M., et al. Habitual abortions in 678 healthy patients: investigation and prevention. Hum Reprod 14 (1999) 2106-2109
3. Arnold J., Holmes Z., Pickering W., Farmer C., Regan L., and Cohen H. Anti-beta2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 113 (2001) 911-914
4. Reznikoff-Etievan M.F., Cayol V., Carbonne B., Robert A., Coulet F., and Milliez J. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG 108 (2001) 1251-1254
5. Stray Pedersen B., and Stray Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 148 (1984) 140-146
6. Kutteh W.H., Wester R., and Kutteh C.C. Multiples of the median: an alternative method for reporting antiphospholipid antibodies in women with recurrent pregnancy loss. Obstet Gynecol 84 (1994) 811-815
7. Barbui T., Finazzi G., and Galli M. Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies. Ann Ital Med Int 12 (1997) 76-83
8. Atterbury J.L., Munn M.B., Groome L.J., and Yarnell J.A. The antiphospholipid antibody syndrome: an overview. J Obstet Gynecol Neonatal Nurs 26 (1997) 522-530
9. Hughes G.R.V., Harris E.N., and Gharavi A.E. The anticardiolipin syndrome. J Rheumatol 13 (1986) 486-491
10. Gleicher N., Harlow L., and Zilberstein M. Regulatory effect of antiphospholipid antibodies on signal transduction: a possible model for autoantibody-induced reproductive failure. Am J Obstet Gynecol 167 (1992) 637-642
11. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., and Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336 (1990) 177-178
12. Triplett D.A. Antiphospholipid antibodies. Arch Pathol Lab Med 126 (2002) 1424-1429
13. Salafia C.M., and Cowchock F.S. Placental pathology and antiphospholipid antibodies: a descriptive study. Am J Perinatol 14 (1997) 435-441
14. Falcon C.R., Martinuzzo M.E., Forastiero R.R., Cerrato G.S., and Carreras L.O. Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 89 (1997) 975-980
15. Lynch A., Byers T., Emlen W., Rynes D., Shetterly S.M., and Hamman R.F. Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy. Obstet Gynecol 93 (1999) 193-198
16. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74 (1995) 1185-1190
17. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Taskforce. Guidelines on testing for lupus anticoagulant. J Clin Pathol 1991; 44: 885-9.
18. Harris E.N. The Second International Anticardiolipin Standardization Workshop/The Kingston Antiphospholipid Antibody (KAPS) Study Group. Am J Clin Pathol 94 (1990) 476-484
19. Tincani A., Allegri F., Sanmarco M., et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 86 (2001) 575-583
20. McNally T., Purdy G., Mackie I.J., Machin S.J., and Isenberg D.A. The use of an anti-beta2 glycoprotein I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 91 (1995) 471-473
21. Martinuzzo M.E., Forastiero R.R., and Carreras L.O. Anti-beta2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 89 (1995) 397-402
22. Lee R.M., Branch D.W., and Silver R.M. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol 185 (2001) 748-753
23. Gris J.C., Quere I., Sanmarco M., et al. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study-NOHA. Thromb Haemost 84 (2000) 228-236
24. Aoki K., Dudkiewicz A.B., Matsuura E., Novotny M., Kaberlein G., and Gleicher N. Clinical significance of beta2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol 172 (1995) 926-931
25. Levy R.A., Avvad E., Oliveira J., and Porto L.C. Placental pathology in antiphospholipid syndrome. Lupus 7 (1998) 81-85
26. Lockshin M.D. Pregnancy loss and antiphospholipid antibodies. Lupus 7 (1998) 86-89
27. Chamley L.W., Duncalf A.M., Mitchell M.D., and Johnson P.M. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 352 (1998) 1037-1038
28. Di Simone N., Meroni P.L., de Papa N., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 43 1 (2000) 140-150